Dobutamine/levosimendan/milrinoneLack of efficacy

被引：0

|

作者：

机构：

来源：

Reactions Weekly | 2024年 / 2014卷 / 1期

关键词：

D O I：

10.1007/s40278-024-61667-1

中图分类号：

学科分类号：

摘要：

引用

收藏

页码：239 / 239

相关论文

共 50 条

[21] MilrinoneLack of efficacy: case report
Reactions Weekly, 2022, 1933 (1) : 285 - 285
[22] MilrinoneLack of efficacy: case report
Reactions Weekly, 2023, 1968 (1) : 200 - 200
[23] MilrinoneLack of efficacy: case report
Reactions Weekly, 2023, 1956 (1) : 336 - 336
[24] MilrinoneLack of efficacy: case report
Reactions Weekly, 2023, 1943 (1) : 437 - 437
[25] MilrinoneLack of efficacy: case report
Reactions Weekly, 2021, 1856 (1) : 277 - 277
[26] The efficacy analysis between levosimendan and dobutamine on post-cardiac surgery patients
Luo Jieyu
Cai, Ruibin
Hong, Zhan
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2016, 68 (16) : C168 - C168
[27] MilrinoneLack of efficacy: case report
Reactions Weekly, 2022, 1901 (1) : 318 - 318
[28] MilrinoneLack of efficacy: case report
Reactions Weekly, 2023, 1949 (1) : 293 - 293
[29] MilrinoneLack of efficacy: case report
Reactions Weekly, 2021, 1857 (1) : 209 - 209
[30] Levosimendan versus dobutamine in cardiac surgery
MD Delgado-Amaya
EC Curiel-Balsera
CJ Joya-Montosa
Critical Care, 19 (Suppl 1):

← 1 2 3 4 5 →